Autorizaciones anuladas y suspendidas, retiradas de lotes, problemas de suministro, notas de seguridad, financiación y nuevos medicamentos — cada día, automáticamente. Última actualización: 12/11/2026 07:45.
n.º EU/1/21/1622 · autorizado 14/02/2022 · Oxbryta is indicated for the treatment of haemolytic anaemia due to sickle cell disease (SCD) in adults and pa… · Pfizer Europe MA EEIG · voxelotor · ATC B06AX
n.º EU/1/21/1601 · autorizado 12/11/2021 · Ronapreve is indicated for:
● Treatment of COVID-19 in adults, adolescents and children aged 2 years and olde… · Roche Registration GmbH · casirivimab / imdevimab · ATC J06BD07
n.º EU/1/13/896 · autorizado 07/04/2014 · Indicated for use as part of an appropriate combination regimen for multi-drug resistant tuberculosis in adult… · Eurocept International B.V. · Para-aminosalicylic acid · ATC J04AA01
n.º EU/1/99/109 · autorizado 01/07/1999 · INTEGRILIN is intended for use with acetylsalicylic acid and unfractionated heparin.
INTEGRILIN is indicated f… · GlaxoSmithKline (Ireland) Limited · Eptifibatide · ATC B01AC16